EFFECT OF NICOTINIC AND MUSCARINIC DRUGS ON AMPHETAMINE- AND APOMORPHINE-INDUCED CIRCLING BEHAVIOUR IN RATSKAAKKOLA S.1981; ACTA PHARMACOL. TOXICOL.; ISSN 0001-6683; DNK; DA. 1981; VOL. 48; NO 2; PP. 162-167; BIBL. 2 P.Article

CIRCLING BEHAVIOUR INDUCED BY INTRANIGRAL INJECTION OF BACLOFEN IN RATSKAAKKOLA S.1980; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1980; VOL. 244; NO 1; PP. 113-122; BIBL. 2 P.Article

CIRCLING BEHAVIOR INDUCED BY INTRANIGRAL INJECTIONS OF GABA AND MUSCIMOL IN RATSKAAKKOLA S; KAARIAINEN I.1980; PSYCHOPHARMACOLOGY; DEU; DA. 1980; VOL. 68; NO 1; PP. 31-36; BIBL. 31 REF.Article

CONTRALATERAL CIRCLING BEHAVIOUR INDUCED BY INTRANIGRAL INJECTION OF TAURINE IN RATSKAAKKOLA S; KAEAERIAEINEN I.1980; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1980; VOL. 46; NO 4; PP. 293-298; BIBL. 2 P.Article

EFFECT OF MUSCARINIC CHOLINERGIC DRUGS ON MORPHINE-INDUCED CATALEPSY, ANTINOCICEPTION AND CHANGES IN BRAIN DOPAMINE METABOLISM.KAAKKOLA S; AHTEE L.1977; PSYCHOPHARMACOLOGY; GERM.; DA. 1977; VOL. 52; NO 1; PP. 7-15; BIBL. 1 P. 1/2Article

Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's diseaseKAAKKOLA, S.Drugs (Basel). 2000, Vol 59, Num 6, pp 1233-1250, issn 0012-6667Article

FLUORESCENCE HISTOCHEMICAL OBSERVATIONS ON THE DISTRIBUTION OF EXOGENOUS DIHYDROISOQUINOLINE IN THE RAT BRAINPANULA P; PARTANEN S; KAAKKOLA S et al.1979; EXPER. BRAIN RES.; DEU; DA. 1979; VOL. 34; NO 1; PP. 155-164; BIBL. 29 REF.Article

TRYPTOPHYLGLYCINE DIPEPTIDE IN ACTH/MSH CELLS OF THE HUMAN HYPOPHYSIS: ITS IDENTIFICATION AND STUDIES ON ITS ANTINOCICEPTIVE EFFECTS IN MICEPARTANEN G; KAAKKOLA S; KAEAERIAEINEN I et al.1979; ACTA PHYSIOL. SCAND.; SWE; DA. 1979; VOL. 107; NO 3; PP. 213-218; BIBL. 17 REF.Article

Effects of COMT inhibitors on striatal dopamine metabolism : a microdialysis studyKAAKKOLA, S; WURTMAN, R. J.Brain research. 1992, Vol 587, Num 2, pp 241-249, issn 0006-8993Article

Animal models of ParkinsonismKAAKKOLA, S; TARÄVÄINEN, H.Pharmacology & toxicology. 1990, Vol 67, Num 2, pp 95-100, issn 0901-9928, 6 p.Article

Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatumKAAKKOLA, S; WURTMAN, R. J.Journal of neurochemistry. 1993, Vol 60, Num 1, pp 137-144, issn 0022-3042Article

Attempts to control Delia spp. with entomopathogenic nematodesVÄNNINEN, I; VAINIO, A; KAAKKOLA, S et al.Bulletin OILB SROP. 1992, Vol 15, Num 4, pp 143-153Conference Paper

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the ratKAAKKOLA, S; MANNISTO, P. T; NISSINEN, E et al.Journal of neural transmission. 1987, Vol 69, Num 3-4, pp 221-228, issn 0300-9564Article

Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferaseNUUTILA, J; KAAKKOLA, S; MANNISTO, P. T et al.Journal of neural transmission. 1987, Vol 70, Num 3-4, pp 233-240, issn 0300-9564Article

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferaseKAAKKOLA, S; GORDIN, A; MÄNNISTÖ, P. T et al.General pharmacology. 1994, Vol 25, Num 5, pp 813-824, issn 0306-3623Article

Laminin is induced in astrocytes of adult brain by injuryLIESI, P; KAAKKOLA, S; DAHL, D et al.EMBO journal (Print). 1984, Vol 3, Num 3, pp 683-686, issn 0261-4189Article

Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patientsKAAKKOLA, S; TERÄVÄINEN, H; AHTILA, S et al.Neurology. 1994, Vol 44, Num 1, pp 77-80, issn 0028-3878Article

Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxiasKAAKKOLA, S; TUOMAINEN, P; MÄNNISTÖ, P. T et al.Acta neurologica scandinavica. 1993, Vol 87, Num 4, pp 309-311, issn 0001-6314Article

Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatumKAAKKOLA, S; TUOMAINEN, P; WURTMAN, R. J et al.Journal of neural transmission - Parkinson's disease and dementia section. 1992, Vol 4, Num 2, pp 143-154, issn 0936-3076Article

Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with Parkinson's diseaseLYYTINEN, J; KAAKKOLA, S; AHTILA, S et al.Movement disorders. 1997, Vol 12, Num 4, pp 497-505, issn 0885-3185Article

Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer's diseaseKAAKKOLA, S; PALO, J; MALMBERG, H et al.Virchows Archiv. 1994, Vol 424, Num 3, pp 315-319, issn 0945-6317Article

Diagnosis and clinical characteristics of ocular Lyme borreliosisKARMA, A; SEPPÄLÄ, I; MIKKILÄ, H et al.American journal of ophthalmology. 1995, Vol 119, Num 2, pp 127-135, issn 0002-9394Article

Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecaponeSUNDBERG, S; SCHEININ, M; OJALA-KARLSSON, P et al.Clinical pharmacology and therapeutics. 1990, Vol 48, Num 4, pp 356-364, issn 0009-9236, 9 p.Article

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the ratNISSINEN, E; LINDEN, I.-B; SCHULTZ, E et al.European journal of pharmacology. 1988, Vol 153, Num 2-3, pp 263-269, issn 0014-2999Article

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferaseMANNISTO, P. T; KAAKKOLA, S; NISSINEN, E et al.Life sciences (1973). 1988, Vol 43, Num 18, pp 1465-1471, issn 0024-3205Article